Procter & Gamble has posted Q2 FY26 net sales of $22.2 billion, up 1 per cent YoY, with organic sales flat as pricing gains offset volume declines.
Diluted EPS fell 5 per cent to $1.78 due to restructuring costs, while core EPS was steady.
Margins softened amid tariff and reinvestment pressures, though cash flow remained strong and FY26 guidance was largely maintained.
Diluted EPS fell 5 per cent to $1.78 due to restructuring costs, while core EPS was steady.
Margins softened amid tariff and reinvestment pressures, though cash flow remained strong and FY26 guidance was largely maintained.
